Myristoylation is important at multiple stages in poliovirus assembly - PubMed (original) (raw)

Myristoylation is important at multiple stages in poliovirus assembly

N Moscufo et al. J Virol. 1991 May.

Abstract

The N-terminal glycine of the VP4 capsid subunit of poliovirus is covalently modified with myristic acid (C14 saturated fatty acid). To investigate the function of VP4 myristoylation in poliovirus replication, amino acid substitutions were placed within the myristoylation consensus sequence at the alanine residue (4003A) adjacent to the N-terminal glycine by using site-directed mutagenesis methods. Mutants which replace the alanine residue with a small hydrophobic residue such as leucine, valine, or glycine displayed normal levels of myristoylation and normal growth kinetics. Replacement with the polar amino acid histidine (4003A.H) also resulted in a level of myristoylation comparable to that of the wild type. However, replacement of the alanine residue with aspartic acid (4003A.D) caused a dramatic reduction (about 40 to 60%) in myristoylation levels of the VP4 precursors (P1 and VP0). In contrast, no differences in modification levels were found in either VP0 and VP4 proteins isolated from mature mutant virions, indicating that myristoylation is required for assembly of the infectious virion. The myristoylation levels of the VP0 proteins found in capsid assembly intermediates indicate that there is a strong but not absolute preference for myristoyl-modified subunits during pentamer formation. Complete myristoylation was observed in mature virions but not in assembly intermediates, indicating that there is a selection for myristoyl-modified subunits during stable RNA encapsidation to form the mature virus particle. In addition, even though mutant infectious virions are fully modified, the severe reduction in specific infectivity of both 4003A.D and 4003A.H purified viruses indicates that the amino acid residue adjacent to the N-terminal glycine apparently has an additional role early during viral infection and that mutations at this position induce pleiotropic effects.

PubMed Disclaimer

Cited by

The role of myristoylation in the membrane association of the Lassa virus matrix protein Z.
Strecker T, Maisa A, Daffis S, Eichler R, Lenz O, Garten W. Strecker T, et al. Virol J. 2006 Nov 5;3:93. doi: 10.1186/1743-422X-3-93. Virol J. 2006. PMID: 17083745 Free PMC article.
Cellular N-myristoyltransferases play a crucial picornavirus genus-specific role in viral assembly, virion maturation, and infectivity.
Corbic Ramljak I, Stanger J, Real-Hohn A, Dreier D, Wimmer L, Redlberger-Fritz M, Fischl W, Klingel K, Mihovilovic MD, Blaas D, Kowalski H. Corbic Ramljak I, et al. PLoS Pathog. 2018 Aug 6;14(8):e1007203. doi: 10.1371/journal.ppat.1007203. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30080883 Free PMC article.
VP0 Myristoylation Is Essential for Senecavirus A Replication.
Xiao P, Meng L, Cui X, Liu X, Qin L, Meng F, Cai X, Kong D, An T, Wang H. Xiao P, et al. Pathogens. 2024 Jul 21;13(7):601. doi: 10.3390/pathogens13070601. Pathogens. 2024. PMID: 39057827 Free PMC article.
Isolation of a Saccharomyces cerevisiae long chain fatty acyl:CoA synthetase gene (FAA1) and assessment of its role in protein N-myristoylation.
Duronio RJ, Knoll LJ, Gordon JI. Duronio RJ, et al. J Cell Biol. 1992 May;117(3):515-29. doi: 10.1083/jcb.117.3.515. J Cell Biol. 1992. PMID: 1572893 Free PMC article.
Foot-and-mouth disease.
Grubman MJ, Baxt B. Grubman MJ, et al. Clin Microbiol Rev. 2004 Apr;17(2):465-93. doi: 10.1128/CMR.17.2.465-493.2004. Clin Microbiol Rev. 2004. PMID: 15084510 Free PMC article. Review.

References

1. Mol Cell Biol. 1988 Oct;8(10):4295-301 - PubMed
1. J Virol. 1987 Apr;61(4):1045-53 - PubMed
1. J Biol Chem. 1987 Jan 25;262(3):1030-6 - PubMed
1. Science. 1987 Nov 27;238(4831):1275-8 - PubMed
1. Cell. 1986 Apr 11;45(1):105-12 - PubMed

Myristoylation is important at multiple stages in poliovirus assembly - PubMed (original) (raw)